Showing results (951-960 of 3,550) with videos related to

Sort By:
Pageof 355
Thoracic Cancer|December 28, 2022
TAPO in first-line osimertinib therapy and continuation of osimertinibChihiro Mimura, Kazumi Kaneshiro, Shodai Fujimoto, et al.
Thoracic Cancer|December 19, 2022
High incidence and reversible bradycardia events following alectinib initiationDongqi Yuan, Fuyi Zhu, Ran Zuo, et al.
Thoracic Cancer|June 13, 2022
Predicting the efficacy of first-line immunotherapy by combining cancer cachexia and tumor burden in advanced non-small cell lung cancerTaichi Miyawaki, Tateaki Naito, Kosei Doshita, et al.
Thoracic Cancer|June 15, 2022
Association of optic nerve sheath lesion and brain or meningeal metastasis caused by lung cancerShuai Song, Dong Chang, Hao Li, et al.
Thoracic Cancer|June 7, 2022
Survival benefits from afatinib compared with gefitinib and erlotinib among patients with common EGFR mutation in first-line settingWang Chun Kwok, James Chung Man Ho, Terence Chi Chun Tam, et al.
Thoracic Cancer|June 7, 2022
Two-year efficacy of SNK01 plus pembrolizumab for non-small cell lung cancer: Expanded observations from a phase I/IIa randomized controlled trialHyung Jun Park, Yong Man Kim, Jae Seob Jung, et al.
Thoracic Cancer|June 7, 2022
Lymphovascular invasion: A non-sized T descriptor for stage IA non-small cell lung cancerJing-Sheng Cai, Xun Wang, Fei Yang, et al.
Thoracic Cancer|November 29, 2022
Chinese expert consensus on the diagnosis and treatment of HER2-altered non-small cell lung cancerShirong Zhang, Wenxian Wang, Chunwei Xu, et al.
Thoracic Cancer|November 30, 2022
RIG-I-mediated innate immune signaling in tumors reduces the therapeutic effect of oncolytic vesicular stomatitis virusPengfei Zhang, Xinyu Han, Weiqi Tan, et al.
Thoracic Cancer|November 30, 2022
Incidental diagnosis of pulmonary cryptococcosis by rebiopsy for epidermal growth factor receptor T790M mutation: A case reportHiroshi Kobe, Shinya Yokoe, Tadashi Ishida
Pageof 355